Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug, new

Hazard identification, step one, means identification of new chemicals or other factors that may cause harmful health effects. Previously, novel hazards were usually observed in case studies or after accidents or other excessive exposures, usually in occupational environments. Today, thorough toxicity studies are required on all pesticides, food additives, and drugs. New chemicals also have to be studied for their potential toxic effects. Thus, earlier hazards were in most cases identified after they had caused harmful effects in humans. Today, most chemical products have been evaluated for their toxicity with experimental animals. Therefore, hazard identification has become a preventive procedure based on safety studies conducted before a chemical compound or product reaches the market, and before individuals are exposed to it. ... [Pg.328]

Applieations for PDA Approval to Market a New Drug, New Drug Produet Exelusivity, (1999) CER, Title 21, Part 314, Volume 5, Seetion 314.108. [Pg.283]

Dear M. Sildenafil for hypertension Old drug, new use. Drug Topics 2005 Jul 11, http //www.drugtopics.com/drugtopics/article/articleDetail.jsp id=169471... [Pg.185]

Austel V, Kutter E. Absorption, distribution, and metabolism of drugs. In Topliss, EJ, editor. Quantitative structure-activity relationships of drugs. New York Academic Press, 1983. p. 437-96. [Pg.458]

Thompson, T., and Pickens, R., eds. Stimulus Properties of Drugs. New York Appleton-Century Crofts, 1971. [Pg.159]

Council on Drugs, New drugs and developments in therapeutics, JAMA, 183, 178 (1963). [Pg.475]

V Austel, E Kutter. Absorption, distribution and metabolism of drugs. In IG Topless, ed. Quantitative Structure-Activity Relationships of Drugs. New York Academic Press, 1980, pp 437-496. [Pg.419]

SR Byrn. Solid State Chemistry of Drugs. New York Academic Press, 1982, pp 1-186. [Pg.619]

Bralow, L., ed. The Physician s Desk Reference (PDR) Pocket Guide to Prescription Drugs. New York Pocketbooks, 2003. [Pg.112]

Japan Pharmaceutical Manufacturers Association. New Drug Development and Approval Process, http //www.jpma.or.jp/12english/guide industry/new drug/new drug.html [accessed August 8, 2002]. [Pg.277]

Julien, RM. (1997). A Primer of Drug Action A Concise, Nontechnical Guide to the Actions, Uses, and Side Effects of Psychoactive Drugs. New York W. H. Freeman. [Pg.497]

Meredith, Robyn, (1999, May 30), Opposition To Plan To Test Welfare Applicants For Drugs, New York Times. [Pg.48]

Jenkins, Philip. Synthetic Panics The Symbolic Politics of Designer Drugs. New York New York University Press, 1999. [Pg.169]

Woodle MC, Storm G (1997) (eds) Long circulating liposomes old drugs, new therapeutics. Springer Verlag Berlin... [Pg.104]

Terms such as new drug, new medication or new treatment should not be used without an explanation that the study drug or treatment is experimental. Advertisements should not promise free medical treatment when the intent is not to charge for taking part in the investigation. The key aspect is that subjects should not enter clinical trials purely because they cannot afford to obtain medical treatment for their illness. [Pg.259]

RJ Linhardt, T Toida. Heparin Oligosaccharides New Analogues Development and Applications. In ZJ Witczak, KA Nieforth. Carbohydrate as Drugs. New York Marcel Dekker, 1997, pp 277-341. [Pg.307]

Pesez, M. and Bartos, J. 1974. Colorimetric and Fluorimetric Analysis of Organic Compounds and Drugs. New York. [Pg.255]

Avorn, Jerry. 2004. Powerful Medicines The Benefits, Risks, and Costs of Prescription Drugs. New York Alfred A. Knopf... [Pg.294]

Berndt, Ernst R. 2005. To Inform or Persuade Direct-to-Consumer Advertising of Prescription Drugs. New England Journal of Medicine 352(4) 325-328. [Pg.295]

Avorn J. Powerful medicines the benefits, risks, and costs of prescription drugs. New York Knopf 2004. [Pg.12]

Some chemical exposures may be hepatic enzyme inducers/inhibitors, altering the effects of drugs like warfarin. Some foods such as mono-amines, will cause reactions in patients given MAOIs grapefruit juice may interact with terfenadine and some other drugs. New diseases may cause problems heart failure causing reduced liver blood flow can reduce the metabolism of drugs like warfarin. [Pg.230]

Keywords Anxiety Anxiety disorders Anxiolytic drugs New drugs ... [Pg.504]

S. Barondes, Better Than Prozac Creating the Next Generation of Psychiatric Drugs (New York Oxford University Press,... [Pg.266]

A series of studies demonstrates a synergistic effect between drug therapies and psychodynamic talk therapies. The effectiveness of each form of therapy used independently is less than their combined use in the case of major depression. See A. Solomon, The Noonday Demon An Atlas of Depression (New York Scribner s, 2001) E. Good, Chronic Depression Study Backs the Pairing of Therapy and Drugs, New York Times (May 18, 2000) L. Altshuler et al., Treatment of Depression in Women A Summary of the Expert Consensus Guidelines, of Psychiatric Practice 7 (May 2001) 185-208. Kleinman, Rethinking Psychiatry p. ii. [Pg.271]

World of Legal Drugs (New Yotk Bantam Books, 1998) Healy, The Creation of Pharmacology D. Healy, let Them Eat Prozac The Unhealthy Relationship between the Pharmaceutical Industry and Depression (New Yotk New Yotk Univetsity Ptess, 2004) K. Gteidet, The Big Fix How the Pharmaceutical Industry Rips Off American Consumers (New Yotk PublicAfFaits, 2003) M. Angell, The Truth about Drug Companies (New Yotk Random House, 2004). [Pg.276]


See other pages where Drug, new is mentioned: [Pg.21]    [Pg.159]    [Pg.177]    [Pg.183]    [Pg.236]    [Pg.258]    [Pg.469]    [Pg.562]    [Pg.327]    [Pg.268]    [Pg.384]    [Pg.326]    [Pg.262]    [Pg.20]    [Pg.193]    [Pg.588]    [Pg.107]    [Pg.21]    [Pg.208]    [Pg.395]   


SEARCH



A Rationale for New Methods in Drug Discovery

Abbreviated New Animal Drug Application ANADA)

Abbreviated New Drug Application

Abbreviated New Drug Applications ANDAs)

Abbreviated new animal drug application

Abbreviated new drug

Abbreviated new drug application (ANDA

Accelerated Access to New Drug Therapies

Analogues as a Means of Discovering New Drugs

Antidepressant drugs, new

Approval of new drugs

Approved new drug applications

Clinical testing of new drugs phase

Computer-assisted new drug

Computer-assisted new drug application

Drug and Cosmetic Industry, New York

Drugs for a New Millennium

Drugs, designing new

Excipients in New Drugs

Exploratory investigational new drug

IND, Investigation New Drug

IND, Investigation New Drug application

Investigation new drug application

Investigational Exemption for a New Drug

Investigational New Drug

Investigational New Drug Application INDA)

Investigational New Drug Exemption

Investigational New Drug IND), applications for

Investigational New Drug application

Investigational New Drugs Application Process

Investigational New Drugs Application Process Phase

Investigational new animal drug

Investigational new drug application (IND

Investigational new drug applications INDAs)

Investigational new drug applications, FDA

Investigational new drug regulations

Investigational new drug studies

Investigational new drug, IND

Investigational new drug/clinical

Investigational new drugs applications for

Investigative new drug application

Journey Toward New Drugs

NDA (New Drug Application

Natural Products as a Resource for Established and New Drugs

Natural products leads for new drugs

New Biological Targets for Drug Development

New Concepts in the Drug Discovery Process

New Drug Amendment

New Drug Application , review

New Drug Application submissions

New Drug Applications (INDs)

New Drug Applications (NDAs)

New Drug Applications approval

New Drug Development: Design, Methodology, and Analysis. By J. Rick Turner

New Drug Policy

New Drugs by Genetic Engineering

New Leads from Old Drugs The SOSA Approach

New Mexico Poison and Drug Information Center

New Platinum Drugs

New and Nonofficial Drugs

New animal drug application

New animal drug application NADA)

New antimalarial drugs

New drug apphcation

New drug application

New drug application contents

New drug application filing

New drug application process

New drug application review process

New drug applications , FDA

New drug approval process

New drug approvals

New drug candidates

New drug delivery systems

New drug development

New drug development process

New drug entity

New drug products

New drug substance

New drug therapy

New drugs appearance

New drugs review

New uses for existing drugs

New uses for old drugs

Notice of Claimed Investigational Exemption for a New Drug

Office of New Animal Drug Evaluation

Office of New Drugs

Old drugs, new uses

Pharmaceutical Evaluation of New Drugs

Plant Products as the Source of New Drugs

Policy Statement for the Development of New Stereoisomeric Drugs

Programmed Packaging A New Drug Delivery System and its Application to Gene Therapy

Psychopharmacology and new drug development

Q1A, stability testing of new drug substances and

Regulatory Aspects of New Drug Development

Regulatory approval of new drugs

Stability Testing of New Drug Substances and Products

Stability testing of new drug substances and

The Emperor’s New Drugs

The Search for New Natural Product Drugs

The investigational new drug application

The new drug application

The role of clinical trials in new drug development

Transforming New Molecular Entities into Drugs

Using Investigational New Drugs

What are drugs and why do we need new ones

Why Drugs Fail - A Study on Side Effects in New Chemical Entities

© 2024 chempedia.info